drugset / Trial / NCT00767715

A Study in the Treatment of Acute Mania

NCT00767715

Phase 4 Terminated 11 enrolled Eli Lilly and Company
RandomizedSingle-groupOpen-labelTreatment

Summary

The purpose of this study is to test the efficacy and total costs of olanzapine versus commonly used conventional antipsychotics in Sweden.

Timeline

Start
2004-10
Primary completion
2005-04
Completion
2005-04

Drugs

EvaluationDrugModalityDoseRoute
Comparator Haloperidol Other / unclassified Oral
Subject Olanzapine Small molecule Oral
Comparator zuclopentixol Unknown Oral

Indications